FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1108411000001101: Mefenamic acid 50mg/5ml oral suspension 125 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22581901000001112 Mefenamic acid 50mg/5ml oral suspension 125 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22582001000001116 Mefenamic acid 50mg/5ml oral suspension 125 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mefenamic acid 50mg/5ml oral suspension 125 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Is pack of Mefenamic acid 50mg/5mL pediatric suspension false Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has active ingredient Mefenamic acid false Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has VMP Mefenamic acid 50mg/5mL pediatric suspension false Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has specific active ingredient Mefenamic acid true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has VMP Mefenamic acid 50mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension 125 ml Has VMP Mefenamic acid 50mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mefenamic acid 50mg/5ml oral suspension (A A H Pharmaceuticals Ltd) 125 ml Is a True Mefenamic acid 50mg/5ml oral suspension 125 ml Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension (Unichem Plc) 125 ml Is a True Mefenamic acid 50mg/5ml oral suspension 125 ml Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension (Chemidex Pharma Ltd) 125 ml Is a True Mefenamic acid 50mg/5ml oral suspension 125 ml Inferred relationship Existential restriction modifier
Mefenamic acid 50mg/5ml oral suspension (Ennogen Healthcare Ltd) 125 ml Is a True Mefenamic acid 50mg/5ml oral suspension 125 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start